Skip to main content

Advertisement

SpringerLink
Log in

Adverse Effects of Nonsystemic Steroids (Inhaled, Intranasal, and Cutaneous): a Review of the Literature and Suggested Monitoring Tool

  • Allergic Skin Diseases (L Fonacier, Section Editor)
  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Inhaled, intranasal, and cutaneous steroids are prescribed by physicians for a plethora of disease processes including asthma and rhinitis. While the high efficacy of this class of medication is well known, the wide range of adverse effects, both local and systemic, is not well elucidated. It is imperative to monitor total steroid burden in its varied forms as well as tracking for possible side effects that may be caused by a high cumulative dose of steroids. This review article highlights the adverse effects of different steroid modalities as well as suggests a monitoring tool to determine steroid totality and side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Barnes P et al. How do corticosteroids work in asthma? Ann Intern Med. 2003;139:359–70.

  2. Kovacs W et al. Metabolism of adrenal steroids. UptoDate.com. 2015.

  3. Roland N, et al. The local side effects of inhaled corticosteroids. Current Understanding and Review of the Literature. Chest. 2004;126:213.

  4. Hanania NA et al. Adverse effects of inhaled corticosteroids. Am J Med. 1995;98:196–208.

    Article  CAS  PubMed  Google Scholar 

  5. Held E et al. Perioral dermatitis in children under steroid inhalation therapy. Ugeskr Laeger. 1997;157:7002–3.

    Google Scholar 

  6. Derendorf H, Nave R, Drollmann A, Cerasoli F, Wurst W. Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Eur Respir J. 2006;28(5):1042–50.

    Article  CAS  PubMed  Google Scholar 

  7. Kelly H, et al. Effect of inhaled glucocorticoids in childhood on adult height. New Engl J Med. 2012;367:904–912.

  8. Kannisto S, et al. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. J Clin Endocrinol Metab. 1999;85:652–657.

  9. Guilbert TW, et al. Growth of preschool children at high risk for asthma 2 years after discontinuation of fluticasone. JACI. 2011;128:956–963. e1–e7.

  10. Skoner DP, et al. Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma. J Asthma. 2011.48(8):848–59.

  11. Scanlon PD et al. Lung Health Study Research Group. Loss of bone density with inhaled triamcinolone in Lung Health Study II. Am J Respir Crit Care Med. 2004;170:1302–9.

    Article  PubMed  Google Scholar 

  12. Wong CA, Walsh LJ, Smith CJP, et al. Inhaled corticosteroid use and bone mineral density in patients with asthma. Lancet. 2000;355(9213):1399–403.

    Article  CAS  PubMed  Google Scholar 

  13. Tattersfield AE et al. Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years. Thorax. 2001;56(4):272–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ip M et al. Decreased bone mineral density in premenopausal asthma patients receiving long term inhaled steroids. Chest. 1994;105(6):1722–7.

    Article  CAS  PubMed  Google Scholar 

  15. van Staa TP, Leufkens HG, Cooper C. Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res. 2001;16:581–8.

    Article  PubMed  Google Scholar 

  16. Kuan YC, How SH, Azian AA, Liam CK, Ng TH, Fauzi AR. Bone mineral density in asthmatic patients on inhaled corticosteroids in a developing country. Ann Thorac Med. 2012;7(2):69–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Boulet LP, et al. Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism. JACI. 1994;94(5):796–803.

  18. Egan JJ et al. A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bonedensity over two years. Eur Respir J. 1999;13(6):1267–75.

    CAS  PubMed  Google Scholar 

  19. Clark DJ, Clark RA, Lipworth BJ. Adrenal suppression with inhaled budesonide and fluticasone propionate given by a large volume spacer in asthmatic children. Thorax. 1996;51:941–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Clark DJ, Lipworth BJ. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients. Thorax. 1997;52:55–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. LoÈnnebo A, GrahneÂn A, Jansson B, Brundin RM, Ling-Andersson A, EckernaÈs S-AÊ. An assessment of the systemic activity of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers. Eur J Clin Pharmacol. 1996;49:459–63.

    Article  Google Scholar 

  22. Kowalski ML et al. Adrenal suppression by inhaled corticosteroids in patients with asthma: a systematic review and quantitative analysis. Allergy Asthma Proc. 2016;37:9–17. A large and current systematic review on inhaled steroids and cortisol suppression.

  23. Hughes JA et al. One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density. Thorax. 1999;54(3):223–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Simons FE et al. Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids. Lancet. 1993;342(8874):776–8.

    Article  CAS  PubMed  Google Scholar 

  25. Allen D. Systemic effects of intranasal steroids: an endocrinologists perspective. Suppl J Allergy Clin Immunol. 2000;106(4 Suppl):S179–90.

  26. Sastre J, Mosges R. Local and systemic safety of intranasal corticosteroids. J Invest Allergy Clin Immunol. 2012;22(1):1–12.

    CAS  Google Scholar 

  27. Lund VJ, Preziosi P, Hercberg S, Hamoir M, Dubreuil C, Pessey JJ, et al. Yearly incidence of rhinitis, nasal bleeding, and other nasal symptoms in mature women. Rhinology. 2006;44:26–31.

  28. Benninger MS et al. Techniques of intranasal steroid use. Otolaryngol Head Neck Surg. 2004;130:5–24.

    Article  PubMed  Google Scholar 

  29. Minshall E et al. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol Head Neck Surg. 1998;118:648–54.

    CAS  PubMed  Google Scholar 

  30. Zitt M, Kosoglou T, Hubbell J. Mometasone furoate nasal spray: a review of safety and systemic effects. Drug Saf. 2007;30:317–26.

    Article  CAS  PubMed  Google Scholar 

  31. Schenkel EJ et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics. 2000;105(2), E22.

    Article  CAS  PubMed  Google Scholar 

  32. Allen DB, Meltzer EO, Lemanske Jr RF, Philpot EE, Faris MA, Kral KM, et al. No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy Asthma Proc. 2002;23:407–13.

    CAS  PubMed  Google Scholar 

  33. Skoner DP, Rachelefsky GS, Meltzer EO, Chervinsky P, Morris RM, Seltzer JM, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics. 2000;105:e23.

    Article  CAS  PubMed  Google Scholar 

  34. Lee DK, Robb FM, Sims EJ, Currie GP, McFarlane LC, Lipworth BJ. Systemic bioactivity of intranasal triamcinolone and mometasone in perennial allergic rhinitis. Br J Clin Pharmacol. 2003;55:310.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Giger R et al. Comparison of once- versus twice-daily use of beclomethasone dipropionate aqueous nasal spray in the treatment of allergic and non-allergic chronic rhinosinusitis. Eur Arch Otorhinolaryngol. 2003;260:135–40.

    CAS  PubMed  Google Scholar 

  36. Moller C et al. Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis. Clin Exp Allergy. 2003;33(6):816–22.

    Article  CAS  PubMed  Google Scholar 

  37. Teper A, Ratner PH. Mometasone furoate nasal spray is safe and effective for one-year treatment of children with perennial allergic rhinitis. J Allergy Clin Immunol. 2008;121 suppl 2:S52.

    Article  Google Scholar 

  38. Oztürk F, Yücetürk AV, Kurt E, Unlü HH, Ilker SS. Evaluation of intraocular pressure and cataract formation following the long-term use of nasal corticosteroids. Ear Nose Throat J. 1998;10:846–8. 850-1.

    Google Scholar 

  39. Derby L, Maier WC. Risk of cataract among users of intranasal corticosteroids. J Allergy Clin Immunol. 2000;105:912–6.

    Article  CAS  PubMed  Google Scholar 

  40. Bui C, et al. Discontinuing nasal steroids might lower intraocular pressure in glaucoma. Am Acad Allergy Asthma Immunol. 2005;116(5):1042–7.

  41. Ahmadi N et al. Intranasal corticosteroids do not affect intraocular pressure or lens opacity: a systematic review of controlled trials. Rhinology. 2015;53(4):290–302. Cohesive systematic review on intranasal steroids and pathology of ophthalmology.

  42. Hengge U et al. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54:1–15.

    Article  PubMed  Google Scholar 

  43. Dey VK. Misuse of topical corticosteroids: a clinical study of adverse effects. Indian Dermatol Online J. 2014;5(4):436–40. Large population review on various adverse effects on topical steroids.

  44. Coondoo A, Phiske M, Verma S, Lahiri K. Side-effects of topical steroids: a long overdue revisit. Indian Dermatol Online J. 2014;5(4):416–25. doi:10.4103/2229-5178.142483.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Thomson KF, Wilkinson SM, Powell S, Beck MH. The prevalence of corticosteroid allergy in two U.K. centres: prescribing implications. Br J Dermatol. 1999;141:863–6.

    Article  CAS  PubMed  Google Scholar 

  46. Wilkinson SM, Jones MF. Corticosteroid usage and binding to arginine: determinants of corticosteroid hypersensitivity. Br J Dermatol. 1996;135:225–30.

    Article  CAS  PubMed  Google Scholar 

  47. Coopman S, Degreef H, Dooms-Goossens A. Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids. The British Journal of Dermatology. 1989;121(1):27–34.

    Article  CAS  PubMed  Google Scholar 

  48. Fonacier L et al. Contact dermatitis: a practice parameter update 2015. J Allergy Clin Immunol Pract. 2015;3(3 Suppl):S1–39. Provides detailed overview on dermatitis and role of steroids.

  49. Berth-Jones J. Topical therapy. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rooks Textbook of Dermatology. 8th ed. 73., vol. 1. UK: Blackwell Science Ltd; 2010. p. 1–73.

    Google Scholar 

  50. Srinivas CR, Lakshmi C. Principles of topical therapy in dermatology. In: Valia RG, Valia AR, editors. IADVL Textbook of Dermatology, vol. 2. 3rd ed. Mumbai, India: Bhalani Publishing House; 2008. p. 1591–618.

    Google Scholar 

  51. Wolverton SE. Comprehensive Dermatologic Drug Therapy. 2nd ed. Philadelphia USA: Saunders Elsevier; 2007. Topical Corticosteroids; pp. 595–624.

  52. Fisher DA. Adverse effects of topical corticosteroid use. West J Med. 1995;162:123–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Furue M, Terao H, Rikihisa W, Urabe K, Kinukawa N, Nose Y, et al. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br J Dermatol. 2003;148:128–33.

    Article  CAS  PubMed  Google Scholar 

  54. Olsen EA, Cornell RC. Topical clobetasol-17-propionate: review of its clinical efficacy and safety. J Am Acad Dermatol. 1986;15:246–55.

    Article  CAS  PubMed  Google Scholar 

  55. Ohman EM, Rogers S, Meenan FO, McKenna TJ. Adrenal suppression following low-dose topical clobetasol propionate. J R Soc Med. 1987;80:422–4. Erratum in: J R Soc Med 1988;81:308.

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Ellison JA et al. Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis. Pediatrics. 2000;105(4 Pt 1):794–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Winthrop University Hospital, 120 Mineola Blvd Suite 410, Mineola, NY, 11501, USA

    Ratika Gupta & Luz S. Fonacier

  2. State University of New York, Stony Brook, NY, USA

    Luz S. Fonacier

Authors
  1. Ratika Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luz S. Fonacier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luz S. Fonacier.

Ethics declarations

Conflict of Interest

Drs. Fonacier and Gupta declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with animal subjects performed by the authors.

With regard to the authors’ research cited in this paper, all procedures were followed in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 2000 and 2008.

Additional information

This article is part of the Topical Collection on Allergic Skin Diseases

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gupta, R., Fonacier, L.S. Adverse Effects of Nonsystemic Steroids (Inhaled, Intranasal, and Cutaneous): a Review of the Literature and Suggested Monitoring Tool. Curr Allergy Asthma Rep 16, 44 (2016). https://doi.org/10.1007/s11882-016-0620-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11882-016-0620-y

Keywords

Search

Navigation